Circulating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old women

scientific article

Circulating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old women is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2015PLoSO..1020744F
P356DOI10.1371/JOURNAL.PONE.0120744
P932PMC publication ID4358991
P698PubMed publication ID25768285
P5875ResearchGate publication ID273952059

P2093author name stringJan Nilsson
Björn Fagerberg
Gunilla Nordin Fredrikson
Ragnar Alm
Ulrica Prahl Gullberg
P2860cites workDefinition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultationQ29547453
Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular diseaseQ31135767
Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequencesQ31135771
Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year-old subjectively clinically healthy men.Q31807209
Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosisQ33207408
T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responsesQ33819043
Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosisQ33890402
High levels of IgM against methylglyoxal-modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetesQ33930928
The immune system in atherosclerosisQ34164644
Immunomodulation of atherosclerosis: implications for vaccine developmentQ34363173
T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoproteinQ34390132
Carotid artery intima-media thickness in patients with Type 2 diabetes mellitus and impaired glucose tolerance: a systematic reviewQ34535616
Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesisQ34737721
Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk StudyQ35212898
Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis.Q50859025
Are serum adiponectin concentrations in a population sample of 64-year-old Caucasian women with varying glucose tolerance associated with ultrasound-assessed atherosclerosis?Q51491965
Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbitsQ71231757
Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery diseaseQ71730634
Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complicationsQ74440973
Autoantibody against the amino acid sequence 661-680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular eventsQ79533802
Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expressionQ80417831
Humoral immune response against defined oxidized low-density lipoprotein antigens reflects structure and disease activity of carotid plaquesQ81652647
A higher level of IgM anti-oxidized LDL antibodies is associated with a lower severity of coronary atherosclerosis in patients on statinsQ82219199
Anti-oxidized LDL antibody levels are reduced in women with hypertensionQ84392366
Autoimmunity in atherosclerosis: a protective response losing control?Q37138017
Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetesQ37207913
Inflammation and immunity in diabetic vascular complicationsQ37260195
IFN-gamma potentiates atherosclerosis in ApoE knock-out miceQ37368296
Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient miceQ37385727
Association between impaired glucose tolerance and carotid atherosclerosis: a study in 64-year-old women and a meta-analysisQ40016955
Induction of T-cell activation by oxidized low density lipoproteinQ41940298
Slightly elevated high-sensitivity C-reactive protein (hsCRP) concentrations are associated with carotid atherosclerosis in women with varying degrees of glucose tolerance.Q43023757
High plasma immunoglobulin (Ig) A and low IgG antibody titers to oxidized low-density lipoprotein are associated with markers of glucose metabolismQ43120687
Percentage white: a new feature for ultrasound classification of plaque echogenicity in carotid artery atherosclerosisQ43217020
Plasma autoantibodies against apolipoprotein B-100 peptide 210 in subclinical atherosclerosisQ43550562
Autoantibodies against modified low-density lipoproteins in coronary artery diseaseQ44125644
Immunoglobulin M Type of Autoantibodies to Oxidized Low-Density Lipoprotein Has an Inverse Relation to Carotid Artery AtherosclerosisQ44608860
Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular eventsQ46125332
Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.Q46326610
Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodiesQ46376396
High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarctionQ46457217
Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) studyQ46517010
Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertensionQ46820023
Prevalence of diabetes and impaired glucose tolerance in 64-year-old Swedish women: experiences of using repeated oral glucose tolerance testsQ46917189
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectautoantibodyQ785022
P304page(s)e0120744
P577publication date2015-03-13
P1433published inPLOS OneQ564954
P1476titleCirculating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old women
P478volume10

Reverse relations

cites work (P2860)
Q59335211Associations between circulating IgG antibodies to Apolipoprotein B-derived peptide antigens and acute coronary syndrome in a Chinese Han population
Q41732468Building Evidence Implicating Novel Cardiovascular Biomarkers in Obstructive Sleep Apnea
Q90298329Inverse association of ApoB and HSP60 antibodies with coronary artery disease in Indian population
Q92357470Lipoprotein(a) Elevation: A New Diagnostic Code with Relevance to Service Members and Veterans
Q92340615Serum Anti-Apo B Antibody Level as Residual CVD Marker in DM Patients under Statin Treatment
Q28553042Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect

Search more.